
Bryan Y. Lee
Examiner (ID: 11209, Phone: (571)270-5606 , Office: P/2445 )
| Most Active Art Unit | 2445 |
| Art Unit(s) | IWPI, 2445, 2615 |
| Total Applications | 446 |
| Issued Applications | 316 |
| Pending Applications | 28 |
| Abandoned Applications | 111 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5206834
[patent_doc_number] => 20070028316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Transgenic non-human Act1-deficient mammals and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/446450
[patent_app_country] => US
[patent_app_date] => 2006-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 19928
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20070028316.pdf
[firstpage_image] =>[orig_patent_app_number] => 11446450
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/446450 | Transgenic non-human Act1-deficient mammals and uses thereof | Jun 1, 2006 | Abandoned |
Array
(
[id] => 5571624
[patent_doc_number] => 20090255003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'Diagnostic and therapeutic target SLC39A11 proteins for neurodegenerative diseases'
[patent_app_type] => utility
[patent_app_number] => 11/920997
[patent_app_country] => US
[patent_app_date] => 2006-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 16662
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20090255003.pdf
[firstpage_image] =>[orig_patent_app_number] => 11920997
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/920997 | Diagnostic and therapeutic target SLC39A11 proteins for neurodegenerative diseases | May 31, 2006 | Abandoned |
Array
(
[id] => 5047777
[patent_doc_number] => 20070266451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Transgenic animals producing low-lactose milk and newly identified human small intestinal extracellular lactase-phlorizin hydrolase (ecLPH) gene'
[patent_app_type] => utility
[patent_app_number] => 11/434332
[patent_app_country] => US
[patent_app_date] => 2006-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6343
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20070266451.pdf
[firstpage_image] =>[orig_patent_app_number] => 11434332
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/434332 | Transgenic animals producing low-lactose milk and newly identified human small intestinal extracellular lactase-phlorizin hydrolase (ecLPH) gene | May 14, 2006 | Issued |
Array
(
[id] => 5892338
[patent_doc_number] => 20060277617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Nucleic acid construct, metabolic disordered non-human animal and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/431891
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13660
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0277/20060277617.pdf
[firstpage_image] =>[orig_patent_app_number] => 11431891
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/431891 | Nucleic acid construct, metabolic disordered non-human animal and use thereof | May 10, 2006 | Issued |
Array
(
[id] => 5047778
[patent_doc_number] => 20070266452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'KSR2 knockout mice and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/431285
[patent_app_country] => US
[patent_app_date] => 2006-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 5950
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20070266452.pdf
[firstpage_image] =>[orig_patent_app_number] => 11431285
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/431285 | KSR2 knockout mice and methods of use thereof | May 9, 2006 | Issued |
Array
(
[id] => 5644450
[patent_doc_number] => 20060282905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Animal models for demyelination disorders'
[patent_app_type] => utility
[patent_app_number] => 11/431372
[patent_app_country] => US
[patent_app_date] => 2006-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 40454
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20060282905.pdf
[firstpage_image] =>[orig_patent_app_number] => 11431372
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/431372 | Animal models for demyelination disorders | May 8, 2006 | Issued |
Array
(
[id] => 5627266
[patent_doc_number] => 20060265771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Monitoring microrna expression and function'
[patent_app_type] => utility
[patent_app_number] => 11/412154
[patent_app_country] => US
[patent_app_date] => 2006-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9980
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20060265771.pdf
[firstpage_image] =>[orig_patent_app_number] => 11412154
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/412154 | Monitoring microrna expression and function | Apr 25, 2006 | Abandoned |
Array
(
[id] => 5224671
[patent_doc_number] => 20070253937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Novel multipotent stem cells and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/412416
[patent_app_country] => US
[patent_app_date] => 2006-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 17314
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20070253937.pdf
[firstpage_image] =>[orig_patent_app_number] => 11412416
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/412416 | Novel multipotent stem cells and use thereof | Apr 25, 2006 | Abandoned |
Array
(
[id] => 4933437
[patent_doc_number] => 20080004212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin'
[patent_app_type] => utility
[patent_app_number] => 11/408659
[patent_app_country] => US
[patent_app_date] => 2006-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16444
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20080004212.pdf
[firstpage_image] =>[orig_patent_app_number] => 11408659
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/408659 | Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin | Apr 20, 2006 | Abandoned |
Array
(
[id] => 4983426
[patent_doc_number] => 20070087985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'MRCK-related compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 11/405735
[patent_app_country] => US
[patent_app_date] => 2006-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11455
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20070087985.pdf
[firstpage_image] =>[orig_patent_app_number] => 11405735
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/405735 | MRCK-related compositions and methods | Apr 17, 2006 | Abandoned |
Array
(
[id] => 5690114
[patent_doc_number] => 20060288429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Genetic screen in drosophila for metastatic behavior'
[patent_app_type] => utility
[patent_app_number] => 11/399880
[patent_app_country] => US
[patent_app_date] => 2006-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12287
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20060288429.pdf
[firstpage_image] =>[orig_patent_app_number] => 11399880
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/399880 | Genetic screen in drosophila for metastatic behavior | Apr 6, 2006 | Abandoned |
Array
(
[id] => 5626110
[patent_doc_number] => 20060264615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Cytokine polypeptides and nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 11/398113
[patent_app_country] => US
[patent_app_date] => 2006-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 58404
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264615.pdf
[firstpage_image] =>[orig_patent_app_number] => 11398113
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/398113 | Cytokine polypeptides and nucleic acids | Apr 4, 2006 | Abandoned |
Array
(
[id] => 5928555
[patent_doc_number] => 20060242724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Receptor'
[patent_app_type] => utility
[patent_app_number] => 11/385261
[patent_app_country] => US
[patent_app_date] => 2006-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20811
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20060242724.pdf
[firstpage_image] =>[orig_patent_app_number] => 11385261
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/385261 | Receptor | Mar 19, 2006 | Abandoned |
Array
(
[id] => 81348
[patent_doc_number] => 07745214
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-29
[patent_title] => 'Methods of obtaining neural stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/375889
[patent_app_country] => US
[patent_app_date] => 2006-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 10
[patent_no_of_words] => 9624
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/745/07745214.pdf
[firstpage_image] =>[orig_patent_app_number] => 11375889
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/375889 | Methods of obtaining neural stem cells | Mar 14, 2006 | Issued |
Array
(
[id] => 5672072
[patent_doc_number] => 20060177426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Method of preserving lyophilized microorganisms for transport, storage and recovery of viable microorganisms'
[patent_app_type] => utility
[patent_app_number] => 11/347334
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2190
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177426.pdf
[firstpage_image] =>[orig_patent_app_number] => 11347334
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/347334 | Method of preserving lyophilized microorganisms for transport, storage and recovery of viable microorganisms | Feb 2, 2006 | Abandoned |
Array
(
[id] => 4994138
[patent_doc_number] => 20070009483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-11
[patent_title] => 'Compositions and methods for the therapeutic treatment of diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/347190
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13701
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20070009483.pdf
[firstpage_image] =>[orig_patent_app_number] => 11347190
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/347190 | Compositions and methods for the therapeutic treatment of diabetes | Feb 2, 2006 | Abandoned |
Array
(
[id] => 5520950
[patent_doc_number] => 20090028931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'Liposomal compositions for parenteral delivery of agents'
[patent_app_type] => utility
[patent_app_number] => 11/883255
[patent_app_country] => US
[patent_app_date] => 2006-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13814
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20090028931.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883255
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883255 | Liposomal compositions for parenteral delivery of agents | Jan 29, 2006 | Abandoned |
Array
(
[id] => 5160426
[patent_doc_number] => 20070173470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Methods for delivering extracellular target into cells'
[patent_app_type] => utility
[patent_app_number] => 11/337109
[patent_app_country] => US
[patent_app_date] => 2006-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6430
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20070173470.pdf
[firstpage_image] =>[orig_patent_app_number] => 11337109
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/337109 | Methods for delivering extracellular target into cells | Jan 22, 2006 | Abandoned |
Array
(
[id] => 5674151
[patent_doc_number] => 20060179506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'In vivo assay for neurite outgrowth in zebrafish and its application in drug screening'
[patent_app_type] => utility
[patent_app_number] => 11/327263
[patent_app_country] => US
[patent_app_date] => 2006-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5996
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20060179506.pdf
[firstpage_image] =>[orig_patent_app_number] => 11327263
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/327263 | In vivo assay for neurite outgrowth in zebrafish and its application in drug screening | Jan 5, 2006 | Issued |
Array
(
[id] => 4758865
[patent_doc_number] => 20080311091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Engineered Dopamine Neurons and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/793797
[patent_app_country] => US
[patent_app_date] => 2005-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 24915
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311091.pdf
[firstpage_image] =>[orig_patent_app_number] => 11793797
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/793797 | Engineered Dopamine Neurons and Uses Thereof | Dec 21, 2005 | Abandoned |